Literature DB >> 15652494

A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting.

Bao-Cheng Huang1, Linda J Foote, Trish K Lankford, Sandra M Davern, Cathy K McKeown, Stephen J Kennel.   

Abstract

A human scFv, 15-9, was selected from a phage display library for binding to murine laminin-1. A diabody was made from the scFv by shortening the linker from 15 to 5 amino acids between the VH and VL sequence. Radioiodinated scFv and diabody were analyzed for size, binding to laminin, and biodistribution in tumor bearing mice. Diabody preparations at concentrations greater than 10 nM were largely dimer forms (approximately 60 kDa) as judged by gel filtration, but diluted diabody was eluted as a monomer (approximately 30 kDa). At low concentrations the radiolabeled diabody did not bind well to laminin. The (125)I diabody had significantly lower accumulation in tumors than did the scFv when injected at lower concentrations. These data indicate that the diabody dimer dissociates at concentrations of about 10nM resulting in monomers with no binding activity for laminin and poor tumor homing properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652494     DOI: 10.1016/j.bbrc.2004.12.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Arie Oosterhof; Toin H van Kuppevelt; Nicole C Smits; Stephen J Kennel
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

2.  Selection for Anti-transferrin Receptor Bispecific T-cell Engager in Different Molecular Formats.

Authors:  Ming-Peng Fu; Zi-Long Guo; Hong-Ling Tang; Hui-Fen Zhu; Guan-Xin Shen; Yong He; Ping Lei
Journal:  Curr Med Sci       Date:  2020-03-13

3.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

4.  Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.

Authors:  Eric C Peterson; Elizabeth M Laurenzana; William T Atchley; Howard P Hendrickson; S Michael Owens
Journal:  J Pharmacol Exp Ther       Date:  2008-01-11       Impact factor: 4.030

5.  Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Authors:  Marcus P Kelly; F-T Lee; Kiki Tahtis; Barbara E Power; Fiona E Smyth; Martin W Brechbiel; Peter J Hudson; Andrew M Scott
Journal:  Cancer Biother Radiopharm       Date:  2008-08       Impact factor: 3.099

6.  Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications.

Authors:  Marta Compte; Ana Alvarez-Cienfuegos; Natalia Nuñez-Prado; Noelia Sainz-Pastor; Ana Blanco-Toribio; Nuria Pescador; Laura Sanz; Luis Alvarez-Vallina
Journal:  Oncoimmunology       Date:  2014-05-23       Impact factor: 8.110

7.  Crystal structures of mono- and bi-specific diabodies and reduction of their structural flexibility by introduction of disulfide bridges at the Fv interface.

Authors:  Jin Hong Kim; Dong Hyun Song; Suk-Jun Youn; Ji Won Kim; Geunyoung Cho; Sun Chang Kim; Hayyoung Lee; Mi Sun Jin; Jie-Oh Lee
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.